CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $400,716
- in 1 filing, $401K under 10b5-1 plans
Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-16 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,680,520 | $18.00 | $30.2M | 4,303,418 |
| 2024-09-16 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +152,480 | $18.00 | $2.7M | 2,652,575 |
| 2024-09-16 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series B Preferred Stock | −18,409,755 | 0 | ||
| 2024-09-16 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series B Preferred Stock | −12,273,169 | 0 | ||
| 2024-09-16 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series C Preferred Stock | −5,835,024 | 0 | ||
| 2024-09-16 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series C Preferred Stock | −10,836,474 | 0 | ||
| 2024-09-16 | FIL Ltd See Remark 1 | Conversion | +54,092 | 54,092 | ||
| 2024-09-16 | FIL Ltd See Remark 1 | Conversion | +606,885 | 660,977 | ||
| 2024-09-16 | FIL Ltd See Remark 1 | Conversion | +352,876 | 1,013,853 | ||
| 2024-09-16 | FIL Ltd See Remark 1 | Conversion · Series Seed Preferred Stock | −54,092 | 0 | ||
| 2024-09-16 | FIL Ltd See Remark 1 | Conversion · Series B Preferred Stock | −606,885 | 0 | ||
| 2024-09-16 | FIL Ltd See Remark 1 | Conversion · Series C Preferred Stock | −352,876 | 0 | ||
| 2024-09-16 | FMR LLC See Remark 1 | Conversion | +10,818 | 10,818 | ||
| 2024-09-16 | FMR LLC See Remark 1 | Conversion | +712,430 | 723,248 | ||
| 2024-09-16 | FMR LLC See Remark 1 | Conversion | +392,085 | 1,115,333 | ||
| 2024-09-16 | FMR LLC See Remark 1 | Conversion · Series Seed Preferred Stock | −10,818 | 0 | ||
| 2024-09-16 | FMR LLC See Remark 1 | Conversion · Series B Preferred Stock | −712,430 | 0 | ||
| 2024-09-16 | FMR LLC See Remark 1 | Conversion · Series C Preferred Stock | −392,085 | 0 | ||
| 2024-09-16 | Biocon Ltd 10% owner | Conversion | +4,327,365 | 4,443,122 | ||
| 2024-09-16 | Biocon Ltd 10% owner | Conversion | +1,080,775 | 1,080,775 |
Page 13 of 14 · 276 trades